Zogenix, Inc. Reports Granting Of Inducement Award Under Nasdaq Listing Rule 5635(C)(4)

Published: Dec 23, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, reported today that it has issued an inducement award to Bradley S. Galer, M.D., the company's newly appointed Executive Vice President and Chief Medical Officer.

Help employers find you! Check out all the jobs and post your resume.

Back to news